25 XP   0   0   10

Renalytix AI plc
Buy, Hold or Sell?

Let's analyse Renalytix together

PenkeI guess you are interested in Renalytix AI plc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Renalytix AI plc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Renalytix AI plc

I send you an email if I find something interesting about Renalytix AI plc.

Quick analysis of Renalytix (30 sec.)










What can you expect buying and holding a share of Renalytix? (30 sec.)

How much money do you get?

How much money do you get?
p0.47
When do you have the money?
1 year
How often do you get paid?
70.0%

What is your share worth?

Current worth
p1.69
Expected worth in 1 year
p-2.25
How sure are you?
67.5%

+ What do you gain per year?

Total Gains per Share
p33.96
Return On Investment
138.6%

For what price can you sell your share?

Current Price per Share
p24.50
Expected price per share
p20.88 - p35.00
How sure are you?
50%

1. Valuation of Renalytix (5 min.)




Live pricePrice per Share (EOD)

p24.50

Intrinsic Value Per Share

p-1,538.37 - p558.41

Total Value Per Share

p-1,536.68 - p560.10

2. Growth of Renalytix (5 min.)




Is Renalytix growing?

Current yearPrevious yearGrowGrow %
How rich?$2.6m$25m-$18.5m-282.3%

How much money is Renalytix making?

Current yearPrevious yearGrowGrow %
Making money-$10.6m-$13.4m$2.8m26.4%
Net Profit Margin-1,829.0%-1,479.5%--

How much money comes from the company's main activities?

3. Financial Health of Renalytix (5 min.)




4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  


Richest
#92 / 120

Most Revenue
#107 / 120

Most Profit
#93 / 120

Most Efficient
#117 / 120

What can you expect buying and holding a share of Renalytix? (5 min.)

Welcome investor! Renalytix's management wants to use your money to grow the business. In return you get a share of Renalytix.

What can you expect buying and holding a share of Renalytix?

First you should know what it really means to hold a share of Renalytix. And how you can make/lose money.

Speculation

The Price per Share of Renalytix is p24.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Renalytix.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Renalytix, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is p1.69. Based on the TTM, the Book Value Change Per Share is p-0.99 per quarter. Based on the YOY, the Book Value Change Per Share is p-5.85 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is p9.48 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Renalytix.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 p% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Share
Usd Eps-0.07-0.3%-0.06-0.3%-0.08-0.3%-0.06-0.2%0.210.8%
Usd Book Value Change Per Share0.030.1%-0.01-0.1%-0.07-0.3%0.000.0%-0.17-0.7%
Usd Dividend Per Share0.000.0%0.120.5%4.6418.9%2.9912.2%1.676.8%
Usd Total Gains Per Share0.030.1%0.110.4%4.5718.6%2.9912.2%1.506.1%
Usd Price Per Share0.19-0.85-1.58-4.29-2.18-
Price to Earnings Ratio-0.67--21.58--4.97--109.93--75.12-
Price-to-Total Gains Ratio5.88--6.82--3.70--167.28--159.33-
Price to Book Ratio9.16-116.09-9.03-49.11-27.88-
Price-to-Total Gains Ratio5.88--6.82--3.70--167.28--159.33-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.3060295
Number of shares3267
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.122.99
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share0.112.99
Gains per Quarter (3267 shares)346.509,772.48
Gains per Year (3267 shares)1,386.0239,089.92
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11547-161137639084639080
23094-3222762781671378170
34641-483414811725119117260
46188-644553415633525156350
57735-805692019541831195440
69282-965830623450238234530
710828-1126969227358544273620
812375-12871107831266950312710
913922-14481246435175357351800
1015469-16091385039083663390890

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%17.023.00.042.5%23.023.00.050.0%
Book Value Change Per Share2.02.00.050.0%4.08.00.033.3%8.012.00.040.0%15.025.00.037.5%20.026.00.043.5%
Dividend per Share1.00.03.025.0%6.00.06.050.0%9.00.011.045.0%28.00.012.070.0%34.00.012.073.9%
Total Gains per Share3.01.00.075.0%9.03.00.075.0%13.07.00.065.0%27.013.00.067.5%32.014.00.069.6%

Fundamentals of Renalytix

About Renalytix AI plc

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. Renalytix Plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; and Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers. The company also has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. Renalytix Plc was incorporated in 2018 and is based in New York, New York.

Fundamental data was last updated by Penke on 2024-04-24 19:25:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is unable to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Renalytix AI plc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Renalytix earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Renalytix to the Health Information Services industry mean.
  • A Net Profit Margin of -1,288.0% means that -12.88 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Renalytix AI plc:

  • The MRQ is -1,288.0%. The company is making a huge loss. -2
  • The TTM is -1,829.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,288.0%TTM-1,829.0%+541.0%
TTM-1,829.0%YOY-1,479.5%-349.5%
TTM-1,829.0%5Y-1,383.4%-445.6%
5Y-1,383.4%10Y-686.0%-697.4%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,288.0%-21.3%-1,266.7%
TTM-1,829.0%-20.1%-1,808.9%
YOY-1,479.5%-29.8%-1,449.7%
5Y-1,383.4%-36.1%-1,347.3%
10Y-686.0%-42.2%-643.8%
1.1.2. Return on Assets

Shows how efficient Renalytix is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Renalytix to the Health Information Services industry mean.
  • -41.7% Return on Assets means that Renalytix generated -0.42 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Renalytix AI plc:

  • The MRQ is -41.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -40.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-41.7%TTM-40.1%-1.7%
TTM-40.1%YOY-31.1%-9.0%
TTM-40.1%5Y276.7%-316.8%
5Y276.7%10Y429.1%-152.4%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-41.7%-6.5%-35.2%
TTM-40.1%-6.0%-34.1%
YOY-31.1%-5.4%-25.7%
5Y276.7%-5.3%+282.0%
10Y429.1%-7.4%+436.5%
1.1.3. Return on Equity

Shows how efficient Renalytix is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Renalytix to the Health Information Services industry mean.
  • -342.4% Return on Equity means Renalytix generated -3.42 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Renalytix AI plc:

  • The MRQ is -342.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -142.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-342.4%TTM-142.2%-200.2%
TTM-142.2%YOY-67.4%-74.8%
TTM-142.2%5Y256.6%-398.8%
5Y256.6%10Y428.3%-171.7%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-342.4%-6.6%-335.8%
TTM-142.2%-6.8%-135.4%
YOY-67.4%-6.7%-60.7%
5Y256.6%-8.4%+265.0%
10Y428.3%-9.6%+437.9%

1.2. Operating Efficiency of Renalytix AI plc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Renalytix is operating .

  • Measures how much profit Renalytix makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Renalytix to the Health Information Services industry mean.
  • An Operating Margin of -1,237.0% means the company generated -12.37  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Renalytix AI plc:

  • The MRQ is -1,237.0%. The company is operating very inefficient. -2
  • The TTM is -1,459.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,237.0%TTM-1,459.7%+222.8%
TTM-1,459.7%YOY-1,152.6%-307.2%
TTM-1,459.7%5Y-1,273.7%-186.1%
5Y-1,273.7%10Y-629.3%-644.4%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,237.0%-23.8%-1,213.2%
TTM-1,459.7%-16.4%-1,443.3%
YOY-1,152.6%-23.4%-1,129.2%
5Y-1,273.7%-18.4%-1,255.3%
10Y-629.3%-31.6%-597.7%
1.2.2. Operating Ratio

Measures how efficient Renalytix is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Health Information Services industry mean).
  • An Operation Ratio of 13.67 means that the operating costs are 13.67 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Renalytix AI plc:

  • The MRQ is 13.674. The company is inefficient in keeping operating costs low. -1
  • The TTM is 17.574. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ13.674TTM17.574-3.900
TTM17.574YOY14.458+3.116
TTM17.5745Y13.389+4.185
5Y13.38910Y7.261+6.128
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ13.6741.370+12.304
TTM17.5741.385+16.189
YOY14.4581.389+13.069
5Y13.3891.398+11.991
10Y7.2611.331+5.930

1.3. Liquidity of Renalytix AI plc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Renalytix is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
  • A Current Ratio of 0.68 means the company has 0.68 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Renalytix AI plc:

  • The MRQ is 0.681. The company is unable to pay all its short-term debts. -2
  • The TTM is 1.466. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ0.681TTM1.466-0.785
TTM1.466YOY2.702-1.236
TTM1.4665Y6.742-5.276
5Y6.74210Y4.120+2.622
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6811.770-1.089
TTM1.4661.813-0.347
YOY2.7022.099+0.603
5Y6.7422.589+4.153
10Y4.1202.589+1.531
1.3.2. Quick Ratio

Measures if Renalytix is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Renalytix to the Health Information Services industry mean.
  • A Quick Ratio of 0.73 means the company can pay off 0.73 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Renalytix AI plc:

  • The MRQ is 0.728. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is -82.139. The company is unable to pay all its short-term debts with the most liquid assets. -2
Trends
Current periodCompared to+/- 
MRQ0.728TTM-82.139+82.867
TTM-82.139YOY-91.871+9.732
TTM-82.1395Y-108.055+25.916
5Y-108.05510Y-53.534-54.522
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7281.059-0.331
TTM-82.1391.223-83.362
YOY-91.8711.723-93.594
5Y-108.0552.117-110.172
10Y-53.5342.107-55.641

1.4. Solvency of Renalytix AI plc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Renalytix assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Renalytix to Health Information Services industry mean.
  • A Debt to Asset Ratio of 0.88 means that Renalytix assets are financed with 87.8% credit (debt) and the remaining percentage (100% - 87.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Renalytix AI plc:

  • The MRQ is 0.878. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.818. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.878TTM0.818+0.060
TTM0.818YOY0.470+0.348
TTM0.8185Y0.407+0.411
5Y0.40710Y0.550-0.142
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8780.379+0.499
TTM0.8180.381+0.437
YOY0.4700.415+0.055
5Y0.4070.411-0.004
10Y0.5500.453+0.097
1.4.2. Debt to Equity Ratio

Measures if Renalytix is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Renalytix to the Health Information Services industry mean.
  • A Debt to Equity ratio of 720.2% means that company has 7.20 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Renalytix AI plc:

  • The MRQ is 7.202. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.949. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ7.202TTM2.949+4.252
TTM2.949YOY1.121+1.829
TTM2.9495Y1.227+1.722
5Y1.22710Y1.414-0.186
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ7.2020.578+6.624
TTM2.9490.575+2.374
YOY1.1210.614+0.507
5Y1.2270.709+0.518
10Y1.4140.616+0.798

2. Market Valuation of Renalytix AI plc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings Renalytix generates.

  • Above 15 is considered overpriced but always compare Renalytix to the Health Information Services industry mean.
  • A PE ratio of -0.67 means the investor is paying -0.67 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Renalytix AI plc:

  • The EOD is -1.058. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.669. Based on the earnings, the company is expensive. -2
  • The TTM is -21.578. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.058MRQ-0.669-0.389
MRQ-0.669TTM-21.578+20.909
TTM-21.578YOY-4.974-16.604
TTM-21.5785Y-109.930+88.351
5Y-109.93010Y-75.124-34.805
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-1.058-1.534+0.476
MRQ-0.669-2.131+1.462
TTM-21.578-2.131-19.447
YOY-4.974-3.492-1.482
5Y-109.930-5.005-104.925
10Y-75.124-4.981-70.143
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Renalytix AI plc:

  • The EOD is -1.232. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.779. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.376. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.232MRQ-0.779-0.452
MRQ-0.779TTM-2.376+1.597
TTM-2.376YOY-5.334+2.958
TTM-2.3765Y-30.309+27.933
5Y-30.30910Y-15.143-15.166
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-1.232-1.376+0.144
MRQ-0.779-1.754+0.975
TTM-2.376-2.380+0.004
YOY-5.334-5.605+0.271
5Y-30.309-3.847-26.462
10Y-15.143-3.041-12.102
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Renalytix is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Health Information Services industry mean).
  • A PB ratio of 9.16 means the investor is paying 9.16 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of Renalytix AI plc:

  • The EOD is 14.486. Based on the equity, the company is expensive. -2
  • The MRQ is 9.165. Based on the equity, the company is overpriced. -1
  • The TTM is 116.092. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD14.486MRQ9.165+5.322
MRQ9.165TTM116.092-106.927
TTM116.092YOY9.029+107.063
TTM116.0925Y49.114+66.978
5Y49.11410Y27.881+21.233
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD14.4861.747+12.739
MRQ9.1651.846+7.319
TTM116.0921.949+114.143
YOY9.0292.960+6.069
5Y49.1143.999+45.115
10Y27.8814.198+23.683
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Renalytix AI plc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.637-0.986+137%-5.852+322%0.038+6750%-13.927+628%
Book Value Per Share--1.6913.110-46%15.903-89%1160.235-100%1030.788-100%
Current Ratio--0.6811.466-54%2.702-75%6.742-90%4.120-83%
Debt To Asset Ratio--0.8780.818+7%0.470+87%0.407+116%0.550+60%
Debt To Equity Ratio--7.2022.949+144%1.121+543%1.227+487%1.414+409%
Dividend Per Share---9.477-100%371.530-100%239.436-100%133.833-100%
Eps---5.791-4.905-15%-6.737+16%-4.498-22%16.491-135%
Free Cash Flow Per Share---4.974-6.778+36%-55.064+1007%-11.884+139%15.134-133%
Free Cash Flow To Equity Per Share---5.346-4.185-22%-132.341+2375%-25.295+373%-12.855+140%
Gross Profit Margin--1.0001.0000%1.0000%33.456-97%16.579-94%
Intrinsic Value_10Y_max--558.405--------
Intrinsic Value_10Y_min---1538.368--------
Intrinsic Value_1Y_max--59.955--------
Intrinsic Value_1Y_min---100.814--------
Intrinsic Value_3Y_max--177.093--------
Intrinsic Value_3Y_min---350.899--------
Intrinsic Value_5Y_max--290.558--------
Intrinsic Value_5Y_min---651.668--------
Market Cap3092365500.000+37%1956394500.00076427814750.000-97%15982480875.000-88%112431726051.000-98%64338531775.500-97%
Net Profit Margin---12.880-18.290+42%-14.795+15%-13.834+7%-6.860-47%
Operating Margin---12.370-14.597+18%-11.526-7%-12.737+3%-6.293-49%
Operating Ratio--13.67417.574-22%14.458-5%13.389+2%7.261+88%
Pb Ratio14.486+37%9.165116.092-92%9.029+2%49.114-81%27.881-67%
Pe Ratio-1.058-58%-0.669-21.578+3125%-4.974+643%-109.930+16328%-75.124+11127%
Price Per Share24.500+37%15.50068.375-77%126.625-88%343.250-95%174.688-91%
Price To Free Cash Flow Ratio-1.232-58%-0.779-2.376+205%-5.334+585%-30.309+3790%-15.143+1844%
Price To Total Gains Ratio9.292+37%5.878-6.817+216%-3.701+163%-167.281+2946%-159.330+2810%
Quick Ratio--0.728-82.139+11382%-91.871+12718%-108.055+14941%-53.534+7453%
Return On Assets---0.417-0.401-4%-0.311-26%2.767-115%4.291-110%
Return On Equity---3.424-1.422-58%-0.674-80%2.566-233%4.283-180%
Total Gains Per Share--2.6378.491-69%365.678-99%239.474-99%119.905-98%
Usd Book Value--2666412.3006558554.438-59%25072473.812-89%2546096142.942-100%9544045719.988-100%
Usd Book Value Change Per Share--0.033-0.012+137%-0.073+322%0.000+6750%-0.174+628%
Usd Book Value Per Share--0.0210.039-46%0.199-89%14.492-100%12.876-100%
Usd Dividend Per Share---0.118-100%4.641-100%2.991-100%1.672-100%
Usd Eps---0.072-0.061-15%-0.084+16%-0.056-22%0.206-135%
Usd Free Cash Flow---7841271.717-83750808.354+968%-86813325.349+1007%65239570.240-112%771932656.453-101%
Usd Free Cash Flow Per Share---0.062-0.085+36%-0.688+1007%-0.148+139%0.189-133%
Usd Free Cash Flow To Equity Per Share---0.067-0.052-22%-1.653+2375%-0.316+373%-0.161+140%
Usd Market Cap38626737.461+37%24437323.700954659834.042-97%199637168.610-88%1404384690.103-98%803652600.408-97%
Usd Price Per Share0.306+37%0.1940.854-77%1.582-88%4.288-95%2.182-91%
Usd Profit---9129987.672-10621658.895+16%-13422291.612+47%161622249.871-106%930099155.226-101%
Usd Revenue--708843.765602367.233+18%950790.438-25%2183823114.622-100%8244712668.677-100%
Usd Total Gains Per Share--0.0330.106-69%4.568-99%2.991-99%1.498-98%
 EOD+6 -2MRQTTM+14 -21YOY+15 -205Y+12 -2410Y+8 -28

3.2. Fundamental Score

Let's check the fundamental score of Renalytix AI plc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.058
Price to Book Ratio (EOD)Between0-114.486
Net Profit Margin (MRQ)Greater than0-12.880
Operating Margin (MRQ)Greater than0-12.370
Quick Ratio (MRQ)Greater than10.728
Current Ratio (MRQ)Greater than10.681
Debt to Asset Ratio (MRQ)Less than10.878
Debt to Equity Ratio (MRQ)Less than17.202
Return on Equity (MRQ)Greater than0.15-3.424
Return on Assets (MRQ)Greater than0.05-0.417
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Renalytix AI plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.077
Ma 20Greater thanMa 5029.350
Ma 50Greater thanMa 10032.305
Ma 100Greater thanMa 20023.957
OpenGreater thanClose25.200
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Net Debt  -929,184-783,992-1,713,176707,634-1,005,543738,769-266,773496,648229,875
Net Working Capital  985,613698,7491,684,362-824,252860,110-756,218103,892-458,469-354,577
Total Other Income Expense Net -63,712-31,536-95,248-254,119-349,367248,116-101,251114,05712,806



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets21,874
Total Liabilities19,207
Total Stockholder Equity2,667
 As reported
Total Liabilities 19,207
Total Stockholder Equity+ 2,667
Total Assets = 21,874

Assets

Total Assets21,874
Total Current Assets9,467
Long-term Assets12,407
Total Current Assets
Cash And Cash Equivalents 5,619
Short-term Investments 1,220
Net Receivables 2,059
Inventory 512
Other Current Assets 57
Total Current Assets  (as reported)9,467
Total Current Assets  (calculated)9,467
+/-0
Long-term Assets
Property Plant Equipment 683
Intangible Assets 11,563
Long-term Assets Other 161
Long-term Assets  (as reported)12,407
Long-term Assets  (calculated)12,407
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities13,897
Long-term Liabilities5,310
Total Stockholder Equity2,667
Total Current Liabilities
Short-term Debt 3,181
Short Long Term Debt 3,063
Accounts payable 2,816
Other Current Liabilities 7,900
Total Current Liabilities  (as reported)13,897
Total Current Liabilities  (calculated)16,960
+/- 3,063
Long-term Liabilities
Long term Debt 5,310
Capital Lease Obligations 118
Long-term Liabilities  (as reported)5,310
Long-term Liabilities  (calculated)5,428
+/- 118
Total Stockholder Equity
Common Stock318
Retained Earnings -118,470
Other Stockholders Equity 120,819
Total Stockholder Equity (as reported)2,667
Total Stockholder Equity (calculated)2,667
+/-0
Other
Capital Stock318
Cash and Short Term Investments 6,839
Common Stock Shares Outstanding 99,930
Liabilities and Stockholders Equity 21,874
Net Debt 2,872
Net Invested Capital 11,040
Net Working Capital -4,430
Property Plant and Equipment Gross 1,682
Short Long Term Debt Total 8,491



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312018-01-012017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-30
> Total Assets 
59,319,335
60,899,202
62,904,734
63,820,604
61,599,783
62,677,133
67,269,721
66,836,881
60,613,365
58,133,511
57,351,883
59,466,444
58,365,047
56,799,348
61,699,220
60,164,362
63,385,566
59,392,696
61,885,202
66,253,569
71,250,443
74,454,709
77,829,515
73,776,273
70,943,812
31,340
72,382,501
28,922
70,640,942
42,480
77,560,062
41,298
91,197
91,015
85,348
102,578
67,265
54,357
44,466
63,258
38,713
30,660
39,802
30,629
19,540
21,874
21,87419,54030,62939,80230,66038,71363,25844,46654,35767,265102,57885,34891,01591,19741,29877,560,06242,48070,640,94228,92272,382,50131,34070,943,81273,776,27377,829,51574,454,70971,250,44366,253,56961,885,20259,392,69663,385,56660,164,36261,699,22056,799,34858,365,04759,466,44457,351,88358,133,51160,613,36566,836,88167,269,72162,677,13361,599,78363,820,60462,904,73460,899,20259,319,335
   > Total Current Assets 
15,600,077
16,015,558
19,850,086
20,139,097
16,406,578
16,693,521
20,671,030
20,538,025
15,582,760
14,945,228
15,971,424
16,560,290
14,157,692
13,777,898
17,371,448
16,939,308
15,595,619
14,613,199
17,708,311
18,958,310
20,072,095
20,371,926
24,430,894
23,158,571
17,968,423
13,261
19,729,669
9,398
17,909,309
21,418
19,779,590
18,896
86,649
78,844
72,837
76,007
56,160
44,407
37,283
47,431
34,426
26,601
35,728
26,882
16,471
9,467
9,46716,47126,88235,72826,60134,42647,43137,28344,40756,16076,00772,83778,84486,64918,89619,779,59021,41817,909,3099,39819,729,66913,26117,968,42323,158,57124,430,89420,371,92620,072,09518,958,31017,708,31114,613,19915,595,61916,939,30817,371,44813,777,89814,157,69216,560,29015,971,42414,945,22815,582,76020,538,02520,671,03016,693,52116,406,57820,139,09719,850,08616,015,55815,600,077
       Cash And Cash Equivalents 
3,165,736
3,250,049
4,442,309
4,506,987
3,092,644
3,146,733
4,710,989
4,680,676
2,714,709
2,603,643
2,911,318
3,018,658
2,569,053
2,500,136
3,552,190
3,463,824
3,798,933
3,559,625
5,351,542
5,729,298
3,920,340
3,979,604
4,916,236
4,660,206
3,749,710
13,095
4,386,988
9,288
4,561,805
20,792
5,350,452
13,293
82,253
74,532
70,076
65,159
54,326
39,928
32,361
41,333
31,040
23,816
33,027
24,682
13,891
5,619
5,61913,89124,68233,02723,81631,04041,33332,36139,92854,32665,15970,07674,53282,25313,2935,350,45220,7924,561,8059,2884,386,98813,0953,749,7104,660,2064,916,2363,979,6043,920,3405,729,2985,351,5423,559,6253,798,9333,463,8243,552,1902,500,1362,569,0533,018,6582,911,3182,603,6432,714,7094,680,6764,710,9893,146,7333,092,6444,506,9874,442,3093,250,0493,165,736
       Short-term Investments 
913,119
937,438
0
0
1,264,127
1,286,236
0
0
755,979
725,050
0
0
665,141
647,298
0
0
634,653
594,674
0
0
615,766
923,815
0
0
969,352
0
1,024,117
0
856,769
0
852,987
982
0
0
613,130
9,295
869,817
7,033
836,376
2,744
0
1,487
0
793,322
0
1,220
1,2200793,32201,48702,744836,3767,033869,8179,295613,13000982852,9870856,76901,024,1170969,35200923,815615,76600594,674634,65300647,298665,14100725,050755,979001,286,2361,264,12700937,438913,119
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
59
59
0
0
0
0
0
18
18
725
-5,587,339
-463
-5,423,905
73
-6,519,526
2,677
1,311
820
747
-6,184,296
1,014
2,059
2,0591,014-6,184,2967478201,3112,677-6,519,52673-5,423,905-463-5,587,3397251818000005959000000000000000000000000
       Inventory 
5,697,040
5,848,771
5,753,091
5,836,854
5,328,551
5,421,745
5,963,486
5,925,115
5,260,302
5,045,089
4,928,828
5,110,554
4,837,900
4,708,118
5,294,687
5,162,974
4,805,392
4,502,684
4,440,414
4,753,855
4,682,662
4,753,449
5,230,352
4,957,964
4,993,035
107
4,920,920
0
4,538,914
435
5,120,123
326
1,617
494
5,587,339
353
5,423,905
736
6,519,526
1,160
0
917
0
6,185,072
0
512
51206,185,072091701,1606,519,5267365,423,9053535,587,3394941,6173265,120,1234354,538,91404,920,9201074,993,0354,957,9645,230,3524,753,4494,682,6624,753,8554,440,4144,502,6844,805,3925,162,9745,294,6874,708,1184,837,9005,110,5544,928,8285,045,0895,260,3025,925,1155,963,4865,421,7455,328,5515,836,8545,753,0915,848,7715,697,040
   > Long-term Assets 
40,688,371
41,772,035
40,076,879
40,660,383
41,632,266
42,360,394
43,001,033
42,724,348
42,078,627
40,357,078
38,212,387
39,621,275
40,967,580
39,868,585
41,179,887
40,155,478
44,478,517
41,676,666
40,027,739
42,853,227
46,539,416
49,605,279
47,730,968
45,245,213
48,862,317
18,079
48,251,262
19,524
47,794,855
21,062
52,696,716
22,402
4,548
12,171
12,511
26,571
11,105
9,950
7,183
15,827
4,287
4,059
4,074
3,747
3,069
12,407
12,4073,0693,7474,0744,0594,28715,8277,1839,95011,10526,57112,51112,1714,54822,40252,696,71621,06247,794,85519,52448,251,26218,07948,862,31745,245,21347,730,96849,605,27946,539,41642,853,22740,027,73941,676,66644,478,51740,155,47841,179,88739,868,58540,967,58039,621,27538,212,38740,357,07842,078,62742,724,34843,001,03342,360,39441,632,26640,660,38340,076,87941,772,03540,688,371
       Property Plant Equipment 
12,129,969
12,453,029
11,814,979
11,987,000
12,646,681
12,867,865
13,281,433
13,195,975
13,216,382
12,675,664
11,889,134
12,327,485
12,340,829
12,009,775
12,582,427
12,269,421
13,112,047
12,286,075
11,803,051
12,636,208
12,304,692
14,721,056
12,379,897
11,735,170
14,032,970
410
13,535,614
278
13,148,027
722
12,534,715
945
2,644
2,603
2,594
2,459
2,632
2,880
2,850
1,723
2,587
2,508
2,373
1,186
1,075
683
6831,0751,1862,3732,5082,5871,7232,8502,8802,6322,4592,5942,6032,64494512,534,71572213,148,02727813,535,61441014,032,97011,735,17012,379,89714,721,05612,304,69212,636,20811,803,05112,286,07513,112,04712,269,42112,582,42712,009,77512,340,82912,327,48511,889,13412,675,66413,216,38213,195,97513,281,43312,867,86512,646,68111,987,00011,814,97912,453,02912,129,969
       Goodwill 
18,774,803
19,274,837
18,557,243
18,827,429
18,836,029
19,165,462
19,359,283
19,234,718
18,479,207
17,723,174
16,559,059
17,169,591
18,093,856
17,608,471
18,196,003
17,743,351
19,796,686
18,549,626
18,109,463
19,387,778
19,951,542
20,253,149
20,555,556
19,485,054
20,131,182
0
19,850,813
0
19,693,700
0
21,682,830
0
0
0
22,554,513
0
23,546,444
23,139,085
23,864,366
22,599,267
0
0
0
23,242,034
0
0
0023,242,03400022,599,26723,864,36623,139,08523,546,444022,554,51300021,682,830019,693,700019,850,813020,131,18219,485,05420,555,55620,253,14919,951,54219,387,77818,109,46318,549,62619,796,68617,743,35118,196,00317,608,47118,093,85617,169,59116,559,05917,723,17418,479,20719,234,71819,359,28319,165,46218,836,02918,827,42918,557,24319,274,83718,774,803
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,937
1,821
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000001,8211,9370000000000000000000000000000000
       Intangible Assets 
9,117,062
9,359,879
9,029,406
9,160,871
9,456,588
9,621,979
9,701,688
9,639,263
9,505,900
9,116,988
9,101,359
9,436,926
9,872,217
9,607,385
9,715,848
9,474,152
11,018,253
10,324,176
10,115,225
10,829,240
13,615,412
13,821,236
14,795,516
14,024,988
14,107,267
17,236
14,074,033
18,287
14,129,060
18,755
17,686,797
17,118
0
0
18,832,356
18,021
21,150,104
16,648
20,948,114
14,020
0
12,991
0
20,366,652
974
11,563
11,56397420,366,652012,991014,02020,948,11416,64821,150,10418,02118,832,3560017,11817,686,79718,75514,129,06018,28714,074,03317,23614,107,26714,024,98814,795,51613,821,23613,615,41210,829,24010,115,22510,324,17611,018,2539,474,1529,715,8489,607,3859,872,2179,436,9269,101,3599,116,9889,505,9009,639,2639,701,6889,621,9799,456,5889,160,8719,029,4069,359,8799,117,062
       Other Assets 
3,030,887
3,111,609
2,977,769
3,021,124
3,560,939
3,623,218
3,597,658
3,574,509
2,951,978
2,831,205
3,168,072
3,284,879
3,239,775
3,152,865
3,147,885
3,069,576
3,311,429
3,102,831
4,149,152
4,442,033
4,638,932
4,477,505
5,667,652
5,372,489
4,113,072
433
4,401,570
959
4,936,778
1,585
5,083,756
2,402
83
4,525
0
7,172
0
10,963
0
0
0
139
0
1,101
0
0
001,101013900010,96307,17204,525832,4025,083,7561,5854,936,7789594,401,5704334,113,0725,372,4895,667,6524,477,5054,638,9324,442,0334,149,1523,102,8313,311,4293,069,5763,147,8853,152,8653,239,7753,284,8793,168,0722,831,2052,951,9783,574,5093,597,6583,623,2183,560,9393,021,1242,977,7693,111,6093,030,887
> Total Liabilities 
38,836,448
39,870,789
45,841,502
46,508,937
41,548,352
42,275,012
47,333,104
47,028,544
42,612,482
40,869,092
40,286,835
41,772,208
40,417,387
39,333,152
44,495,188
43,388,306
44,312,272
41,520,893
43,942,174
47,043,975
54,246,543
57,420,516
62,676,768
59,412,658
56,877,177
809
57,356,141
755
55,504,687
1,304
57,476,306
5,336
4,076
4,118
5,322
7,476
7,292
8,557
15,051
20,089
19,870
21,775
21,705
23,662
21,031
19,207
19,20721,03123,66221,70521,77519,87020,08915,0518,5577,2927,4765,3224,1184,0765,33657,476,3061,30455,504,68775557,356,14180956,877,17759,412,65862,676,76857,420,51654,246,54347,043,97543,942,17441,520,89344,312,27243,388,30644,495,18839,333,15240,417,38741,772,20840,286,83540,869,09242,612,48247,028,54447,333,10442,275,01241,548,35246,508,93745,841,50239,870,78938,836,448
   > Total Current Liabilities 
20,310,794
20,851,737
29,481,709
29,910,952
23,525,749
23,937,203
28,169,480
27,988,226
24,789,550
23,775,343
23,462,427
24,327,485
22,341,387
21,742,058
24,269,689
23,665,945
23,090,143
21,635,617
21,145,844
22,638,492
27,392,743
28,298,740
32,012,811
30,345,633
23,392,152
809
24,391,475
755
22,866,797
1,304
23,116,597
3,383
3,809
3,720
5,240
7,263
7,239
8,542
15,037
12,205
13,334
14,287
14,684
16,136
15,173
13,897
13,89715,17316,13614,68414,28713,33412,20515,0378,5427,2397,2635,2403,7203,8093,38323,116,5971,30422,866,79775524,391,47580923,392,15230,345,63332,012,81128,298,74027,392,74322,638,49221,145,84421,635,61723,090,14323,665,94524,269,68921,742,05822,341,38724,327,48523,462,42723,775,34324,789,55027,988,22628,169,48023,937,20323,525,74929,910,95229,481,70920,851,73720,310,794
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
213
161
141
226
139
0
130
0
4,823
4,601
4,719
4,602
4,593
4,700
3,181
3,1814,7004,5934,6024,7194,6014,823013001392261411612130000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
121
161
141
226
53
0
0
0
4,660
4,473
4,590
4,473
4,463
4,569
3,063
3,0634,5694,4634,4734,5904,4734,660000532261411611210000000000000000000000000000000
       Accounts payable 
9,097,797
9,340,102
15,646,102
15,873,903
9,467,416
9,632,996
17,435,756
17,323,568
9,637,155
9,242,874
15,038,943
15,593,428
9,258,412
9,010,046
15,905,700
15,510,023
9,650,098
9,042,206
14,064,867
15,057,681
9,711,618
16,107,978
16,916,728
16,035,731
10,588,577
809
16,068,424
315
10,017,441
1,304
15,969,804
2,899
1,829
864
1,066
1,765
1,659
2,386
3,063
7,281
4,262
4,148
3,199
2,936
3,368
2,816
2,8163,3682,9363,1994,1484,2627,2813,0632,3861,6591,7651,0668641,8292,89915,969,8041,30410,017,44131516,068,42480910,588,57716,035,73116,916,72816,107,9789,711,61815,057,68114,064,8679,042,2069,650,09815,510,02315,905,7009,010,0469,258,41215,593,42815,038,9439,242,8749,637,15517,323,56817,435,7569,632,9969,467,41615,873,90315,646,1029,340,1029,097,797
       Other Current Liabilities 
11,212,997
11,511,636
13,835,608
14,037,049
14,058,334
14,304,207
10,733,724
10,664,659
15,152,395
14,532,470
8,423,484
8,734,057
13,082,975
12,732,012
8,363,988
8,155,922
13,440,045
12,593,411
7,080,977
7,580,811
17,681,125
12,190,762
15,096,083
14,309,902
12,803,576
0
8,323,051
440
12,849,357
0
7,146,793
949
39
113
3,948
5,359
5,580
6,026
11,974
12,538,502
300
31
9
10
10
7,900
7,900101093130012,538,50211,9746,0265,5805,3593,948113399497,146,793012,849,3574408,323,051012,803,57614,309,90215,096,08312,190,76217,681,1257,580,8117,080,97712,593,41113,440,0458,155,9228,363,98812,732,01213,082,9758,734,0578,423,48414,532,47015,152,39510,664,65910,733,72414,304,20714,058,33414,037,04913,835,60811,511,63611,212,997
   > Long-term Liabilities 
9,475,374
9,727,734
8,723,173
8,850,179
9,881,573
10,054,396
10,652,429
10,583,887
8,834,480
8,473,038
9,633,131
9,988,304
10,820,825
10,530,546
12,085,872
11,785,219
12,368,436
11,589,306
15,525,445
16,621,359
19,314,502
21,642,472
23,344,420
22,128,678
24,998,839
809
24,006,730
315
24,013,516
1,304
24,425,832
1,953
267
398
82
213
53
15
14
7,884
6,536
7,488
7,021
7,526
5,858
5,310
5,3105,8587,5267,0217,4886,5367,884141553213823982671,95324,425,8321,30424,013,51631524,006,73080924,998,83922,128,67823,344,42021,642,47219,314,50216,621,35915,525,44511,589,30612,368,43611,785,21912,085,87210,530,54610,820,8259,988,3049,633,1318,473,0388,834,48010,583,88710,652,42910,054,3969,881,5738,850,1798,723,1739,727,7349,475,374
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,544
173
232
53
53
53
0
14
0
0
0
0
0
0
0
00000001405353532321731,5440000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
457
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000457000000000000000000000000000000
> Total Stockholder Equity
27,545,110
28,278,726
24,084,823
24,435,489
28,357,583
28,853,543
28,841,888
28,656,308
26,558,970
25,472,372
23,956,599
24,839,877
25,783,159
25,091,501
25,522,465
24,887,556
26,580,174
24,905,799
27,191,934
29,111,365
32,067,132
32,269,946
34,763,489
32,953,059
30,747,620
30,531
23,541,223
28,167
20,309,571
41,176
24,488,649
35,962
89,194
86,897
80,026
95,102
59,973
45,800
29,415
43,169
18,843
8,885
18,097
6,967
-1,491
2,667
2,667-1,4916,96718,0978,88518,84343,16929,41545,80059,97395,10280,02686,89789,19435,96224,488,64941,17620,309,57128,16723,541,22330,53130,747,62032,953,05934,763,48932,269,94632,067,13229,111,36527,191,93424,905,79926,580,17424,887,55625,522,46525,091,50125,783,15924,839,87723,956,59925,472,37226,558,97028,656,30828,841,88828,853,54328,357,58324,435,48924,084,82328,278,72627,545,110
   Common Stock
621,589
638,144
620,155
629,184
655,072
666,529
666,896
662,605
610,841
585,850
519,955
539,126
540,148
525,658
551,221
537,509
543,668
509,420
516,377
552,827
572,036
580,684
596,206
565,156
538,658
171
486,820
175
457,816
192
462,861
192
219
219
219
233
220
220
220
241
229
229
286
286
290
318
318290286286229229241220220220233219219219192462,861192457,816175486,820171538,658565,156596,206580,684572,036552,827516,377509,420543,668537,509551,221525,658540,148539,126519,955585,850610,841662,605666,896666,529655,072629,184620,155638,144621,589
   Retained Earnings 
26,923,521
27,640,583
23,464,668
23,806,305
27,702,511
28,187,014
28,174,991
27,993,703
25,948,129
24,886,522
23,436,644
24,300,752
25,243,011
24,565,843
24,971,243
24,350,047
26,036,507
24,396,379
26,675,557
28,558,538
31,495,095
31,689,262
34,167,283
32,387,903
30,208,962
-2,877
23,054,403
-5,977
19,851,755
-9,744
24,025,788
34,852
-59,938
-68,846
-77,622
3,771
-97,548
-112,870
-127,565
-52,961
-144,671
-155,115
-167,221
-178,325
-188,479
-118,470
-118,470-188,479-178,325-167,221-155,115-144,671-52,961-127,565-112,870-97,5483,771-77,622-68,846-59,93834,85224,025,788-9,74419,851,755-5,97723,054,403-2,87730,208,96232,387,90334,167,28331,689,26231,495,09528,558,53826,675,55724,396,37926,036,50724,350,04724,971,24324,565,84325,243,01124,300,75223,436,64424,886,52225,948,12927,993,70328,174,99128,187,01427,702,51123,806,30523,464,66827,640,58326,923,521
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-98
0
-595
0
-594
0
-1,915
1,030
-143
-223
0
0
0
0
0
0
0
0
0
0
0
00000000000-223-1431,030-1,9150-5940-5950-980000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
76,457
0
0
0
0
0
0
0
0
0
0
000000000076,45700000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-09-30)

Gross Profit (+$)
totalRevenue2,893
Cost of Revenue-2,489
Gross Profit404404
 
Operating Income (+$)
Gross Profit404
Operating Expense-42,281
Operating Income-39,388-41,877
 
Operating Expense (+$)
Research Development13,328
Selling General Administrative26,471
Selling And Marketing Expenses-
Operating Expense42,28139,799
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-0
Net Interest Income-
 
Pretax Income (+$)
Operating Income-39,388
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-43,805-39,388
EBIT - interestExpense = 0
-43,808
-43,808
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--43,805
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-43,805
Tax Provision-3
Net Income From Continuing Ops-43,808-43,808
Net Income-43,808
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Technical Analysis of Renalytix
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Renalytix. The general trend of Renalytix is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Renalytix's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Renalytix AI plc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 27.00 < 27.00 < 35.00.

The bearish price targets are: 25.00 > 24.00 > 20.88.

Tweet this
Renalytix AI plc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Renalytix AI plc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Renalytix AI plc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Renalytix AI plc. The current macd is -1.53468656.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Renalytix price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Renalytix. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Renalytix price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Renalytix AI plc Daily Moving Average Convergence/Divergence (MACD) ChartRenalytix AI plc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Renalytix AI plc. The current adx is 16.82.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Renalytix shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Renalytix AI plc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Renalytix AI plc. The current sar is 49.13.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Renalytix AI plc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Renalytix AI plc. The current rsi is 34.08. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Renalytix AI plc Daily Relative Strength Index (RSI) ChartRenalytix AI plc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Renalytix AI plc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Renalytix price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Renalytix AI plc Daily Stochastic Oscillator ChartRenalytix AI plc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Renalytix AI plc. The current cci is -188.24181994.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Renalytix AI plc Daily Commodity Channel Index (CCI) ChartRenalytix AI plc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Renalytix AI plc. The current cmo is -54.30328578.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Renalytix AI plc Daily Chande Momentum Oscillator (CMO) ChartRenalytix AI plc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Renalytix AI plc. The current willr is -95.45454545.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Renalytix AI plc Daily Williams %R ChartRenalytix AI plc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Renalytix AI plc.

Renalytix AI plc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Renalytix AI plc. The current atr is 2.6954867.

Renalytix AI plc Daily Average True Range (ATR) ChartRenalytix AI plc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Renalytix AI plc. The current obv is 4,193,293.

Renalytix AI plc Daily On-Balance Volume (OBV) ChartRenalytix AI plc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Renalytix AI plc. The current mfi is 64.62.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Renalytix AI plc Daily Money Flow Index (MFI) ChartRenalytix AI plc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Renalytix AI plc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-20MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.

6.3. Candlestick Patterns

Renalytix AI plc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Renalytix AI plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.077
Ma 20Greater thanMa 5029.350
Ma 50Greater thanMa 10032.305
Ma 100Greater thanMa 20023.957
OpenGreater thanClose25.200
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Renalytix with someone you think should read this too:
  • Are you bullish or bearish on Renalytix? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Renalytix? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Renalytix AI plc

I send you an email if I find something interesting about Renalytix AI plc.


Comments

How you think about this?

Leave a comment

Stay informed about Renalytix AI plc.

Receive notifications about Renalytix AI plc in your mailbox!